Neurotrope, Inc.·4

Mar 21, 9:51 PM ET

Neurotrope, Inc. 4

4 · Neurotrope, Inc. · Filed Mar 21, 2017

Insider Transaction Report

Form 4
Period: 2017-03-17
Phares Shana
Director
Transactions
  • Award

    Stock Option (right to buy)

    2017-03-17+10,00010,000 total
    Exercise: $19.10From: 2018-03-17Exp: 2027-03-17Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]Represents the annual option grant to each of the Issuer's non-employee directors on the fifth business day after the Issuer's filing of its Annual Report on Form 10-K pursuant to the Issuer's Nonemployee Director Compensation Policy. Such option grant is subject to stockholder approval of the Issuer's 2017 Equity Incentive Plan under which the option was granted.

Documents

1 file
  • 4
    v462248_4.xmlPrimary

    OWNERSHIP DOCUMENT